Series date: 
03/01/2024 - 7:00am EST to 12/31/2024 - 11:59pm EST

Series Overview

Learners will have a refresher on what FH is, what the guidelines are to screen and treat it, and learn about tools available at Geisinger to make screening easier.  

Target Audience

This course is designed for physicians, advanced practitioners, nurses, pharmacists, and medical students. 

Planning Committee

Michael Lesko, DO, Activity Director
Samuel Gidding, MD
David Rolston, MD
Marie Kobylinski, MD
Matthew Nelson, DO
Shuping Ge, MD
Caroline deRichemond, CRNP
Elizabeth Bordy, PA-C
Timothy Shuey, DO
Tyler Schubert

Accreditation 

In support of improving patient care, Geisinger College of Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Credit Designation 

Geisinger College of Health Sciences designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the educational activity.

Geisinger College of Health Sciences designates this activity for 1 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the educational activity. 

Geisinger College of Health Sciences has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

 

Disclosure Policy

Geisinger College of Health Sciences must ensure balance, independence, objectivity, and scientific rigor in all its continuing education activities. Each person in a position to control the educational content of a CE activity must disclose the existence or non-existence of any financial relationship that they have with an ineligible company. There is no minimum financial threshold; individuals must disclose all financial information, regardless of the amount. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Any identified conflicts of interest will be resolved prior to the start of the activity. Subsequently, disclosure information is made available prior to the start of the activity. 

Series location: 
Geisinger Medical Center
100 N. Academy Ave
Danville, PA 17822
United States
See map: Google Maps

Sessions

Session Date
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - March 05, 2024 03/05/2024 - 12:00pm to 1:00pm EST
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - March 7, 2024 03/07/2024 - 8:00am to 9:00am EST
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - March 8, 2024 03/08/2024 - 8:00am to 9:00am EST
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - March 14, 2024 03/14/2024 - 12:00pm to 1:00pm EDT
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation -April 02, 2024 04/02/2024 - 11:00am to 12:00pm EDT
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - April 09, 2024 04/09/2024 - 1:00pm to 2:00pm EDT
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - April 18, 2024 04/18/2024 - 7:30am to 8:30am EDT
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - April 29, 2024 (A) 04/29/2024 - 12:00pm to 1:00pm EDT
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - April 29, 2024 (B) 04/29/2024 - 1:00pm to 2:00pm EDT
Familial Hypercholesterolemia Screening, Diagnosis, and Evaluation - August 19, 2024 08/19/2024 - 11:00am to 12:00pm EDT

Pages